Artemis Medicare Services Limited, a leading healthcare provider, has announced robust financial results for the first quarter, along with details on the utilization of proceeds from its recent debenture issue.

Strong Financial Performance

For the quarter ended June 30, Artemis Medicare Services reported:

• Consolidated gross revenue of Rs 2,681.00 crore, up 14.40% year-over-year
• Net revenue from operations increased by 14.20% to Rs 2,550.00 crore
• EBITDA rose by 19.10% to Rs 483.00 crore, with a margin of 19.00%
• Net profit grew by 28.20% to Rs 212.00 crore

The company's flagship hospital in Gurgaon showed impressive metrics:

• Average gross revenue per occupied bed (ARPOB) reached Rs 83,900.00
• Net revenue from operations increased by 16.00% to Rs 2,412.00 crore
• Bed capacity utilization stood at 61.20%
• Revenues from overseas patients surged by 31.40% to Rs 704.00 crore, contributing 29.00% to net revenue

Debenture Issue Utilization

Artemis Medicare Services also reported on the utilization of proceeds from its Rs 330.00 crore Preferential Issue of Compulsorily Convertible Debentures:

The unutilized funds have been deployed in fixed deposits across various banks, earning returns between 5.75% to 7.30%. The monitoring report, issued by CARE Ratings Limited, confirmed no deviations from the disclosed objectives.

Strategic Developments

Chairman Onkar Kanwar highlighted several key developments:

• Addition of new beds at the flagship hospital's third tower
• Signing of a binding MoU with Dr. Vidya Sagar Kaushalya Devi Memorial Health Centre for a proposed Medical Services Agreement
• Launch of India's first private Geriatrics & Longevity Department
• Partnership with KIMS, Hyderabad for heart-lung transplants

Outlook

Kanwar expressed confidence in the company's growth trajectory, stating, "We remain focused on sustainable growth through operational excellence, geographic expansion and strategic partnerships, as we continue building Artemis into one of India's most trusted healthcare brands."

The company's strong performance, strategic initiatives, and prudent utilization of funds position Artemis Medicare Services for continued growth in the healthcare sector.

Artemis Medicare Services Limited , a leading healthcare provider, has reported robust financial results for the first quarter of fiscal year 2026, demonstrating significant growth across key metrics.

Financial Highlights

The company's consolidated net revenue from operations for Q1 FY26 reached ₹254.96 crore, marking a substantial 14.2% increase from ₹223.20 crore in the same quarter last year. This growth was driven by strong performance in both domestic and international markets.

Profitability also saw a notable improvement, with consolidated net profit after tax rising to ₹21.20 crore, up 28.3% from ₹16.52 crore in Q1 FY25. The company's EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) grew by 19.1% to ₹48.30 crore, with an EBITDA margin of 19.0%.

Operational Performance

Artemis Hospital Gurgaon, the company's flagship facility, reported impressive operational metrics:

International Patient Revenue

The company saw a significant boost in its international patient segment, with revenues from overseas patients increasing by 31.4% to ₹70.40 crore. This segment now contributes 29% to the company's net revenue, highlighting Artemis's growing reputation as a destination for medical tourism.

Strategic Developments

During the quarter, Artemis Medicare Services made several strategic moves to enhance its capabilities and expand its reach:

1. Added new beds at the flagship hospital's third tower, strengthening capacity and improving unit economics.
2. Signed a binding Memorandum of Understanding (MoU) with Dr. Vidyasagar Kaushalya Devi Memorial Health Centre for a proposed Medical Services Agreement, marking an important step in expanding in North India. The company paid an advance deposit of ₹54.00 crore in connection with this arrangement.
3. Launched India's first private Geriatrics & Longevity Department.
4. Partnered with KIMS, Hyderabad for heart-lung transplants, underscoring the company's commitment to advanced, patient-centric care.

Management Commentary

Onkar Kanwar, Chairman of Artemis Medicare Services Ltd, expressed satisfaction with the company's performance, stating, "We are pleased to announce a strong start to FY26, with Q1 delivering consistent growth and resilient operational performance despite being a seasonally soft quarter. Our continued focus on cost optimization, operational efficiency, and disciplined execution has enabled us to maintain healthy profitability and margins."

He further added, "Our highest-ever ARPOB, driven by an optimized case and payer mix and strong international patient inflow, reinforces our position as a leader in Medical Value Travel."

Equity Issuance

The company issued 13,30,000 equity shares to its Managing Director under the Artemis Medicare Management Stock Option Plan - 2021 during the quarter, which have been duly listed on the stock exchanges.

Artemis Medicare Services Limited continues to focus on sustainable growth through operational excellence, geographic expansion, and strategic partnerships as it builds its position as one of India's most trusted healthcare brands.